JSPR
Jasper Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Jasper Therapeutics, Inc.
0.53
−0.01 · −1.24%
post 0.53 0.00%
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Velan Capital Investment ManagementVelan Capital | $1.1M | 21.66% | 0.00% | |
| 2 | Acorn Capital AdvisorsAcorn Capital | $604,027 | 11.65% | +1.89% | |
| 3 | Kingdon Capital ManagementKingdon | $569,237 | 10.97% | 0.00% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $493,421 | 9.51% | −0.05% | |
| 5 | Rock Springs Capital ManagementRock Springs | $463,406 | 8.93% | 0.00% | |
| 6 | Carlyle GroupCarlyle | $448,866 | 8.65% | 0.00% | |
| 7 | GSA Capital PartnersGSA Capital Partners | $225,000 | 4.34% | +2701.81% | |
| 8 | Millennium ManagementMillennium | $204,999 | 3.95% | −69.90% | |
| 9 | Lion Point CapitalLion Point Capital | $195,765 | 3.77% | 0.00% | |
| 10 | Geode Capital ManagementGeodeindex-like | $111,086 | 2.14% | −16.96% | |
| 11 | Renaissance TechnologiesRenaissance Technologies | $100,156 | 1.93% | +34.03% | |
| 12 | Citadel AdvisorsCitadel | $96,156 | 1.85% | +208.23% | |
| 13 | Jane Street GroupJane Street | $78,030 | 1.50% | +84.39% | |
| 14 | BlackRockBlackRockindex-like | $71,413 | 1.38% | −29.92% | |
| 15 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $63,126 | 1.22% | 0.00% | |
| 16 | ADAR1 Capital ManagementADAR1 | $58,940 | 1.14% | 0.00% | |
| 17 | QuarryQuarry | $55,374 | 1.07% | 0.00% | |
| 18 | UBS GroupUBS | $24,737 | 0.48% | −27.56% | |
| 19 | Jain GlobalJain Global | $21,549 | 0.42% | +184.01% | |
| 20 | Advisor Group HoldingsAdvisor | $19,298 | 0.37% | +12.24% | |
| 21 | State StreetState Streetindex-like | $18,818 | 0.36% | 0.00% | |
| 22 | Northern TrustNorthern Trustindex-like | $17,632 | 0.34% | +21.13% | |
| 23 | Diker ManagementDiker | $15,000 | 0.29% | 0.00% | |
| 24 | Qube Research & TechnologiesQube Research & Technologies | $14,197 | 0.27% | new | |
| 25 | XTX TopcoXTX Topco | $14,064 | 0.27% | −15.28% |
44 managers report $5.2M of Jasper Therapeutics on form 13F for the quarter ended Jun 30 '26. 9 of them hold 80% of it; Velan Capital is largest at 21.66%.
Largest filed tie
—
Expected move
No implied move.
No implied move.
No implied move.